№ files_lp_4_process_2_41786
File format: docx
Character count: 909
File size: 60 KB
Form used to obtain parental or guardian consent for the administration of specific medications to a child, including detailed child and prescriber information and signatures.
Year:
2026
Document type:
Medical consent form
Intended audience:
Parents or guardians of children
Child information included:
Name, date of birth, allergies
Medication details included:
Name, dose, administration times, start and stop dates, known side effects
Prescriber information included:
Name of prescribing health professional
Signatures required:
Parent/guardian, healthcare provider
Administration methods:
Oral, ear, eye, nebulizer, skin, other
Purpose:
Authorization for administration of medication to a child
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2017
Version:
1.0
Date:
April 2017
Organization:
Department of Veterans Affairs, Office of Information and Technology (OI&T)
Product:
CTT & DM NDS Allergies Patch GMRA455
Related Applications:
VistA Adverse Reaction Tracking (ART) v.4.0; Computerized Patient Record System (CPRS) v.1.0; Kernel v.8.0
Patch Dependency:
XU8676
Document Type:
Deployment, Installation, Back-Out, and Rollback Guide
Deployment Method:
FORUM Patch Module; Kernel Installation Distribution System (KIDS)
Initial Deployment Site:
Central Plains HCS, Oklahoma City, OK
Deployment Scope:
All VA VistA instances running CPRS v.1.0 and ART v.4.0
Deployment Period:
Thirty days
Authors:
Mantech Mission Solutions and Services
Revision History:
Initial Draft December 18, 2016; Technical Writer Review December 19, 2016; Updates through April 2017
Year:
Not specified
Person:
Carla Hernandez
Subject:
Patient allergy data entry
Topic:
Electronic health records documentation
Document type:
Training scenario and procedural instructions
System / Platform:
EHRclinic
Medical category:
Drug allergy documentation
Allergy type:
Drug allergy
Allergy detail:
Codeine
Onset:
Adulthood
Recorded date and time:
September 10, 2010 - 12:00 am
Severity:
Severe
Status:
Active
Adverse reaction:
Breathing
Data source:
Patient intake sheet
Primary activity:
Adding allergy information to a patient face sheet
Target audience:
Medical students or healthcare trainees using EHRclinic
Organisation:
Felixstowe Nursery School
Country:
England and Wales
Subject:
Health care and allergy management in early years education
Document type:
Institutional policy
Policy area:
Safeguarding and welfare requirement – health
Target group:
Nursery staff, parents, carers and visitors
Applicable setting:
Early years and preschool education environment
Regulatory references:
Managing Medicines in Schools and Early Years Settings (DCSF, March 2005); Food Information Regulation (2014)
Main risks addressed:
Food allergies, nut allergies, insect stings, animal allergies, anaphylaxis
Key medical treatments referenced:
Adrenalin auto-injectors (Epipen, Jext, Emerade)
Implementation measures:
Healthcare plans, risk assessments, staff training, allergen management procedures
Parent responsibilities:
Provide medical information, medication and emergency contacts
Staff responsibilities:
Allergy awareness, hygiene procedures, supervision of food activities, emergency response
Food safety practice:
Allergen information records and monitoring of snack ingredients
Document type:
School health procedure and individual healthcare plan template
Subject:
Severe allergies in pupils
Sector:
Education and school health services
Responsible organizations:
Schools; NHS; Royal Hospital for Sick Children; St John’s Hospital
Region:
West Lothian
Target group:
Pupils with diagnosed allergies
Participants:
Parents; school staff; healthcare professionals
Medical condition:
Severe allergy; food allergy; asthma (where applicable)
Required documentation:
Individual Healthcare Plan; Request for Use of Medication and/or Administration of Healthcare in School; Symptom and Action Flowcharts
Medication types:
Antihistamine; Salbutamol inhaler; Adrenaline pen
Healthcare coordination:
Parent; General Practitioner; hospital or allergy clinic
Medication management:
Parent-supplied medication in original packaging labelled with pupil’s name and dose
Plan review period:
At least annually; every three months in Early Learning and Childcare settings or at the start of a new term
School settings covered:
Early Learning and Childcare; Primary School; Secondary School; Special School
Key procedures:
Storage and accessibility of adrenaline pens; dietary control; curriculum adjustments; staff awareness of pupils with allergies
Personal data fields:
Pupil name; date of birth; CHI number; address; school; parent contacts; healthcare contacts
Year:
2026
Region:
Global
Topic:
Immunology / Nutrition
Document Type:
Scientific overview
Institution:
Medical research and clinical guidelines
Author:
Not specified
Target Audience:
Healthcare professionals, researchers, medical students
Allergy Mechanisms:
Ig-E mediated, Non Ig-E mediated
Common Allergens:
Peanuts, tree nuts, fish, soy, wheat, eggs, milk, shellfish, fruits, vegetables
Symptoms:
Cutaneous, gastrointestinal, respiratory, cardiovascular
Genetic Factors:
HLA-DQ locus, filaggrin, interleukin-10, STAT6, FOXP3
Enzyme Deficiencies:
Lactase, sucrose, isomaltase
Related Conditions:
Celiac disease, inflammatory bowel disease, migraine, food intolerance
Natural History:
Onset and resolution ages vary by allergen type
Endorsed Tests:
Ig-E antibody assays, clinical observation for non-Ig-E reactions
Classification:
Ig-E mediated Class 1 and Class 2 allergens
Pathogenesis Details:
Mast cell activation, cytokine release, T cell mediated inflammation
Clinical Manifestations:
FPIES, FPIAP, EoE, oral allergy syndrome, acute urticaria, atopic dermatitis
Note:
Year
Topic:
Food allergies, eczema
Document Type:
Patient Handout
Author:
Leah Lalor, Patricia Todd
Target Audience:
Parents of children with eczema
Expert Reviewer:
Vy Kim
Committee Reviewers:
Erin Mathes, Irene Lara-Corrales
Year:
2026
Region / City:
United States
Topic:
Occupational illness compensation, impairment evaluation
Document type:
Letter, response form
Organization / Institution:
U.S. Department of Labor, Office of Workers’ Compensation Programs
Author:
Unknown
Target audience:
Claimants under EEOICPA
Period of validity:
Indefinite
Approval date:
Not provided
Modification date:
Not provided
Year:
2022
Region / City:
Fermilab
Topic:
Workplace Safety, Occupational Injury and Illness Management
Document Type:
Program
Institution:
Fermilab
Author:
Angela Aparicio, Bridget Iverson, Dave Baird, John P. Cassidy, Nancy Grossman
Target Audience:
Fermilab employees, users, affiliates, subcontractors
Effective Period:
Ongoing
Approval Date:
September 2022
Revision Dates:
June 2020, November 2018, July 2013, July 2011, March 2011
Document type:
Memorandum
Request type:
Non-substantive change request
Subject:
Acute Respiratory Illness reporting for cruise ships
Program:
Phased Approach to the Resumption of Cruise Ship Passenger Operations
OMB Control Number:
0920-1335
OMB expiration date:
January 31, 2026
Issuing organization:
Centers for Disease Control and Prevention
Division:
National Center for Emerging and Zoonotic Infectious Diseases
Program contact:
Rudith Vice
Contact address:
1600 Clifton Road, NE, Atlanta, Georgia 30333
Contact phone:
404-718-7292
Contact email:
[email protected]
Date of document:
October 23, 2023
Effective date of proposed changes:
Upon receipt of OMB approval
Geographic scope:
United States
Regulatory reference:
42 CFR part 71
Target respondents:
Cruise ship physicians
Reporting system:
REDCap
Related attachment:
Attachment H_10202023
Year:
2024
Jurisdiction:
California, USA
Document type:
Model Program / Guidelines
Authority:
California Division of Occupational Safety and Health (Cal/OSHA)
Regulation reference:
California Code of Regulations, title 8, section 5199.1(a)(2)(A)
Scope:
Employers with occupational exposure to zoonotic aerosol transmissible pathogens
Target audience:
Employers and occupational safety personnel
Publication date:
July 2024
Copyright holder:
State of California, Department of Industrial Relations
Year:
2023
Region / city:
California
Theme:
Workplace safety, construction
Document type:
Template
Organization / institution:
State of California, Department of Industrial Relations
Author:
Cal/OSHA Publications Unit
Target audience:
Employers in the construction industry
Period of validity:
Ongoing
Approval date:
July 2023
Modification date:
Not specified
Year:
2022
Region / city:
Victoria, Australia
Topic:
Mental health, substance use, addiction
Document type:
Guidance
Institution:
Victorian Government, Department of Health
Author:
Victorian Government
Target audience:
Mental health and wellbeing and alcohol and other drug service providers
Period of validity:
Not specified
Approval date:
July 2022
Revision date:
Not specified
Year:
2023
Region / City:
California
Topic:
Workplace safety, staffing agencies
Document Type:
Policy Template
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Staffing agencies, employers
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2021
Region / City:
California
Topic:
Occupational Health and Safety
Document Type:
Template
Organization / Institution:
Cal/OSHA
Author:
California Division of Occupational Safety and Health (Cal/OSHA)
Target Audience:
Employers in non-high hazard industries
Validity Period:
Ongoing
Approval Date:
January 2021
Revision Date:
N/A
Year:
2024
Region / City:
Kent, Medway
Topic:
Child safeguarding, fabricated illness, medical guidance
Document Type:
Guidance
Organization:
Kent Safeguarding Children Multi-Agency Partnership (KSCMP), Medway Safeguarding Children Partnership (MSCP)
Author:
Kent Safeguarding Children Multi-Agency Partnership (KSCMP), Medway Safeguarding Children Partnership (MSCP)
Target Audience:
Multi-agency professionals working with children
Review Period:
2027
Policy Review Date:
December 2027
Date Approved:
December 2024
Note:
Year
Year:
2017
Region / City:
North Hampton, MA
Subject:
Homeless Veterans with Serious Mental Illness Services
Document Type:
Solicitation Notice
Organ / Institution:
Department of Veterans Affairs
Author:
Corey L. Labbe
Target Audience:
Contractors
Period of Performance:
06-01-2017 to 05-31-2018 (with multiple option years)
Approval Date:
05-22-2017
Amendment Date:
N/A
Performance Location:
North Hampton VA Medical Center
NAICS Code:
624221
Contract Number:
VA241-17-Q-0332
Contact Information:
Corey L. Labbe, Contract Specialist, 207-623-8411 X-2229
Email:
[email protected]
Additional Information:
Full and open competition, NAICS code 624221 - Temporary Shelter Services
Context:
This document outlines a combined synopsis/solicitation for providing residential services for homeless veterans with serious mental illness at the North Hampton VA Medical Center.
Year:
Not specified
Region / City:
North Northamptonshire
Topic:
Mental Health, Severe Mental Illness, Social Care
Document Type:
Request for Quotation (RFQ)
Organization / Institution:
North Northamptonshire Council
Author:
Not specified
Target Audience:
Potential suppliers
Effective Period:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2023
Region / City:
Bow
Theme:
Mental Health, Law Enforcement
Document Type:
General Order
Agency / Institution:
Bow Police Department
Author:
Bow Police Department
Target Audience:
Bow Police Department Officers
Effective Date:
3/1/2023
Approval Date:
2/10/2023
Amendment Date:
N/A
Year:
2026
Region / City:
United States
Topic:
Health Reporting
Document Type:
Reporting Form
Institution:
CDC (Centers for Disease Control and Prevention)
Author:
Centers for Disease Control and Prevention
Target Audience:
Cruise ship operators, public health authorities
Period of Validity:
Until 01/30/2026
Date of Approval:
01/30/2026
Date of Changes:
N/A